FMR1 and fragile X syndrome: Replacing the heterogeneous, and likely dynamic, mixture of FMR1 isoforms with only a single isoform is likely to result in only a partial rescue, which is consistent with gene therapy studies in a mouse model of FXS [67,71,72,73].